Suppr超能文献

在局部麻醉下使用低剂量纯乙醇对外周静脉畸形进行门诊经皮治疗。

Outpatient percutaneous treatment of deep venous malformations using pure ethanol at low doses under local anesthesia.

机构信息

Department of Plastic Surgery, Hospital A.C. Camargo, São Paulo, SP, Brazil.

出版信息

Clinics (Sao Paulo). 2010;65(9):837-40. doi: 10.1590/s1807-59322010000900004.

Abstract

INTRODUCTION

Venous malformations are the most frequent vascular malformation. Deep venous malformations are located in subcutaneous tissue or in the muscles. Percutaneous sclerotherapy is the treatment of choice, and the use of ethanol at low doses has not yet been described.

OBJECTIVE

To analyze the results of treating Deep venous malformations patients with low doses of ethanol.

METHODS

Thirty-nine patients treated between July 1995 and June 2007 were followed up prospectively over a median period of 18 months. Twenty-nine were female (74.4%) and 10 were male (25.6%), with ages ranging from 11 to 59 years (median of 24 years). All of the lesions affected limbs, and the main symptom reported was pain (97.4%). Each patient underwent fortnightly alcohol application sessions under local anesthesia on an outpatient basis. The lesions were classified into three groups according to size using nuclear magnetic resonance imaging: small, up to 3 cm (4 patients); medium, between 3 and 15 cm (27 patients); and large, greater than 15 cm (8 patients).

RESULTS

The symptoms completely disappeared in 14 patients (35.9%) and improved in 24 (61.5%). The lesion size reduced to zero in 6 patients (15.4%) and decreased in 32 (82%). The median number of sessions was 7. There were no complications in 32 patients (82%), while 3 presented local paresthesia (7.7%), 2 superficial trombophlebites (5.1%), 1 skin ulcer (2.6%), and 1 case of hyperpigmentation (2.6%).

CONCLUSION

Outpatient treatment for Deep venous malformations patients using ethanol at low doses was effective, with a low complication rate.

摘要

简介

静脉畸形是最常见的血管畸形。深部静脉畸形位于皮下组织或肌肉中。经皮硬化疗法是首选治疗方法,而尚未描述低剂量乙醇的应用。

目的

分析低剂量乙醇治疗深部静脉畸形患者的结果。

方法

1995 年 7 月至 2007 年 6 月期间,对 39 例患者进行了前瞻性随访,中位随访时间为 18 个月。29 例为女性(74.4%),10 例为男性(25.6%),年龄 11-59 岁(中位数 24 岁)。所有病变均累及四肢,主要症状为疼痛(97.4%)。每位患者均在局麻下接受两周一次的酒精应用治疗,在门诊进行。根据磁共振成像结果,根据病变大小将患者分为三组:小,直径<3cm(4 例);中,3-15cm(27 例);大,直径>15cm(8 例)。

结果

14 例(35.9%)患者症状完全消失,24 例(61.5%)患者症状改善。6 例(15.4%)患者病变完全消失,32 例(82%)患者病变缩小。中位治疗次数为 7 次。32 例(82%)患者无并发症,3 例出现局部感觉异常(7.7%),2 例出现浅表血栓性静脉炎(5.1%),1 例出现皮肤溃疡(2.6%),1 例出现皮肤色素沉着(2.6%)。

结论

低剂量乙醇治疗深部静脉畸形患者的门诊治疗有效,并发症发生率低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c80b/2954733/b9f9bef36f23/cln-65-09-837-g001.jpg

相似文献

2
Ethanol sclerotherapy of superficial venous malformation: a new procedure.
Dermatology. 2010;220(4):376-80. doi: 10.1159/000305525. Epub 2010 May 13.
3
Ethanol sclerotherapy of head and neck venous malformations.
Einstein (Sao Paulo). 2014 Apr;12(2):181-6. doi: 10.1590/s1679-45082014ao2844.
4
Ethanol-Gel Sclerotherapy of Venous Malformations: Effectiveness and Safety.
AJR Am J Roentgenol. 2017 Dec;209(6):1390-1395. doi: 10.2214/AJR.16.17603. Epub 2017 Sep 20.
5
Ethanol sclerotherapy for the management of craniofacial venous malformations: the interim results.
Korean J Radiol. 2009 May-Jun;10(3):269-76. doi: 10.3348/kjr.2009.10.3.269. Epub 2009 Apr 22.
6
Sclerotherapy for vascular malformations: complications and a review of techniques to avoid them.
J Plast Reconstr Aesthet Surg. 2013 Feb;66(2):215-23. doi: 10.1016/j.bjps.2012.09.002. Epub 2012 Oct 8.
7
Radio-opaque ethylcellulose-ethanol is a safe and efficient sclerosing agent for venous malformations.
Eur Radiol. 2011 Dec;21(12):2647-56. doi: 10.1007/s00330-011-2213-4. Epub 2011 Aug 7.
8
Venous Malformations Sclerotherapy: Outcomes, Patient Satisfaction and Predictors of Treatment Success.
Cardiovasc Intervent Radiol. 2019 Dec;42(12):1695-1701. doi: 10.1007/s00270-019-02338-y. Epub 2019 Sep 19.
9
Sclerotherapy after embolization of draining vein: a safe treatment method for venous malformations.
J Vasc Surg. 2008 Jun;47(6):1292-9. doi: 10.1016/j.jvs.2008.01.010. Epub 2008 Apr 3.

引用本文的文献

1
2
Effectiveness of polidocanol sclerotherapy in alleviating symptoms in patients with venous malformations.
J Vasc Surg Venous Lymphat Disord. 2024 Mar;12(2):101698. doi: 10.1016/j.jvsv.2023.101698. Epub 2023 Oct 27.
3
Effectiveness of Polidocanol in the Treatment of Venous Malformations: A Meta-Analysis.
Front Pediatr. 2022 Jul 28;10:925318. doi: 10.3389/fped.2022.925318. eCollection 2022.
4
Current Controversies and the State of the Art in Endovascular Treatment of Vascular Malformations.
J Interv Med. 2019 Apr 30;1(2):65-69. doi: 10.19779/j.cnki.2096-3602.2018.02.01. eCollection 2018 May.
5
Ethanol sclerotherapy of head and neck venous malformations.
Einstein (Sao Paulo). 2014 Apr;12(2):181-6. doi: 10.1590/s1679-45082014ao2844.
6
Pediatrics in Clinics: highlights.
Clinics (Sao Paulo). 2012 Aug;67(8):859-64. doi: 10.6061/clinics/2012(08)01.

本文引用的文献

3
Incidence of soft tissue injury and neuropathy after embolo/sclerotherapy for congenital vascular malformation.
J Vasc Surg. 2008 Nov;48(5):1286-91. doi: 10.1016/j.jvs.2008.06.058. Epub 2008 Oct 1.
4
Venous malformations: classification, development, diagnosis, and interventional radiologic management.
Radiol Clin North Am. 2008 May;46(3):545-97, vi. doi: 10.1016/j.rcl.2008.02.008.
5
Sclerotherapy after embolization of draining vein: a safe treatment method for venous malformations.
J Vasc Surg. 2008 Jun;47(6):1292-9. doi: 10.1016/j.jvs.2008.01.010. Epub 2008 Apr 3.
7
Surgical management of venous malformations.
Phlebology. 2007;22(6):276-82. doi: 10.1177/026835550702200608.
9
Venous angiomata: treatment with sclerosant foam.
Ann Vasc Surg. 2005 Jul;19(4):457-64. doi: 10.1007/s10016-005-4656-z.
10
Percutaneous treatment of low flow vascular malformations.
J Vasc Interv Radiol. 2004 May;15(5):431-45. doi: 10.1097/01.rvi.0000124949.24134.cf.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验